The night waking that comes with perimenopause is its own specific torture — not the slow drift into insomnia, but the sudden 3am wide-awake-for-no-reason that feels almost cruel. When women first hear about glycine, it sounds almost too simple. But the thermoregulation mechanism alone is worth taking seriously, because that mechanism is exactly what goes wrong during this stage of life.
Learn more about Rose →Glycine works in the hypothalamus to promote peripheral vasodilation, which allows heat to dissipate from the skin and lowers core body temperature. This cooling effect is the same physiological trigger the brain uses to initiate and maintain deep sleep. During perimenopause, estrogen fluctuations destabilize the hypothalamic thermostat, making glycine's direct action on this pathway unusually relevant — it essentially bypasses the hormonal disruption and acts downstream.
Human clinical trials have shown that 3g of glycine taken before bed measurably shortens sleep onset latency — the time between lying down and actually falling asleep. Unlike sedating antihistamines or even some prescription sleep aids, glycine does not produce next-day sedation or cognitive blunting. For perimenopausal women already dealing with brain fog, a sleep aid that doesn't add to that burden the next morning matters considerably.
In the spinal cord and brainstem, glycine functions as an inhibitory neurotransmitter, reducing neuronal excitability in a manner similar — though distinct — to GABA. Perimenopause is associated with increased sympathetic nervous system activation as estrogen declines, which contributes to the hyperarousal many women describe as lying awake with a buzzing, restless quality. Glycine's inhibitory action helps bring that activation down without pharmacological force.
Studies using polysomnography — the gold-standard objective sleep measurement — have found that glycine supplementation increases slow-wave (deep) sleep and improves subjective sleep satisfaction ratings. This distinction matters because perimenopausal sleep disruption often shows up as shallow, unrestorative sleep rather than simply fewer hours. Women may sleep seven hours and wake exhausted; glycine appears to address the architecture problem, not just the duration.
Glycine is a co-agonist at NMDA glutamate receptors, meaning it is required for those receptors to activate fully. This relationship is complex, but at physiological concentrations achieved through supplementation, glycine appears to help regulate rather than overstimulate these receptors, which play a role in anxiety and threat-processing circuits. For women whose 3am waking is accompanied by racing, catastrophising thoughts, this receptor-level calming effect is part of glycine's proposed mechanism.
Glycine is one of three amino acids required to synthesize glutathione, the body's primary intracellular antioxidant. Research has found that glutathione levels decline with age partly due to glycine insufficiency rather than lack of the other precursors. Poor sleep accelerates oxidative stress, and oxidative stress worsens sleep quality — glycine's role in breaking this cycle is indirect but physiologically grounded.
The dose consistently used in sleep research — 3 grams taken 30 to 60 minutes before bed — is well within the range the body handles routinely, since glycine is both synthesized endogenously and consumed in protein-rich foods. No significant adverse effects have been reported in sleep trials, and it does not interact with common perimenopausal medications such as antidepressants or blood pressure treatments in ways that are clinically documented as problematic. This is not a signal to skip checking with a prescriber, but the safety ceiling is genuinely high compared to many sleep interventions.
Melatonin supplementation, particularly at the doses most over-the-counter products contain, can suppress the pineal gland's endogenous melatonin production over time and may interact with the already-changing hormonal landscape of perimenopause. Glycine operates through amino acid and neurotransmitter pathways entirely separate from the endocrine system, making it a functionally neutral choice from a hormonal perspective. For women already navigating significant hormonal change, that neutrality has practical value.
One reason glycine remains underused is that it requires a few grams per dose — too much for a standard capsule — which means most people use it in powdered form. Glycine has a mild, genuinely pleasant sweetness due to its molecular structure, making it one of the few supplements that is actually easy to take consistently as a nightly ritual. Consistency is the factor that separates supplements that work in research from supplements that work in real life, and glycine's palatability gives it an unusual practical advantage.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.